TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 37 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $76,000 | +52.0% | 45,219 | +80.0% | 0.00% | +100.0% |
| Q2 2022 | $50,000 | -79.3% | 25,119 | -72.7% | 0.00% | -77.8% |
| Q1 2022 | $242,000 | +11.0% | 92,019 | +16.7% | 0.01% | +12.5% |
| Q4 2021 | $218,000 | +275.9% | 78,861 | +429.3% | 0.01% | +300.0% |
| Q3 2021 | $58,000 | -40.2% | 14,900 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $97,000 | -21.1% | 14,900 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $123,000 | +2.5% | 14,900 | +44.7% | 0.01% | +25.0% |
| Q4 2020 | $120,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |